SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 47 filers reported holding SUNESIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $167,000 | -36.7% | 636,784 | 0.0% | 0.00% | – |
| Q1 2020 | $264,000 | -38.0% | 636,784 | -49.7% | 0.00% | – |
| Q4 2019 | $426,000 | -3.8% | 1,265,294 | +105.5% | 0.00% | – |
| Q3 2019 | $443,000 | +27.7% | 615,734 | +28.7% | 0.00% | – |
| Q2 2019 | $347,000 | -9.2% | 478,478 | +51.9% | 0.00% | – |
| Q1 2019 | $382,000 | +185.1% | 314,975 | -3.3% | 0.00% | – |
| Q4 2018 | $134,000 | -58.8% | 325,764 | +100.0% | 0.00% | – |
| Q3 2018 | $325,000 | +2.2% | 162,882 | +8.6% | 0.00% | – |
| Q2 2018 | $318,000 | -14.7% | 150,040 | +9.4% | 0.00% | – |
| Q1 2018 | $373,000 | -19.4% | 137,196 | +9.3% | 0.00% | – |
| Q4 2017 | $463,000 | +292.4% | 125,489 | +105.2% | 0.00% | – |
| Q3 2017 | $118,000 | -28.5% | 61,146 | 0.0% | 0.00% | – |
| Q2 2017 | $165,000 | -35.3% | 61,146 | -1.9% | 0.00% | – |
| Q1 2017 | $255,000 | +24.4% | 62,353 | +9.8% | 0.00% | – |
| Q4 2016 | $205,000 | -17.0% | 56,782 | +0.2% | 0.00% | – |
| Q3 2016 | $247,000 | – | 56,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |